Dickinson Helena, Lukasser Melanie, Mayer Günter, Hüttenhofer Alexander
Center of Chemistry & Biomedicine, Innsbruck Medical University, Innrain 80-82, 6020, Innsbruck, Austria.
Methods Mol Biol. 2015;1296:213-24. doi: 10.1007/978-1-4939-2547-6_20.
Systematic Evolution of Ligands by Exponential Enrichment (SELEX) is an in vitro process enabling selection of nucleic acid molecules binding to target ligands with high binding affinity and specificity. The selection process involves several rounds of two successive steps: (1) binding of the oligonucleotides to the target under stringent conditions and (2) amplification of the target-bound nucleic acids by polymerase chain reaction. Using this strategy, RNA or DNA aptamers are selected upon recognition and binding to specific surface structures of the target. Aptamers generated during the final rounds of selection can be notably used in applications dedicated to diagnosis of diseases or therapeutic approaches.
指数富集配体的系统进化技术(SELEX)是一种体外技术,能够筛选出与靶标配体具有高亲和力和特异性结合的核酸分子。筛选过程包括连续几个轮次的两个步骤:(1)在严格条件下寡核苷酸与靶标的结合;(2)通过聚合酶链反应扩增与靶标结合的核酸。利用这种策略,RNA或DNA适配体可通过识别并结合靶标的特定表面结构而被筛选出来。在最后几轮筛选中产生的适配体可显著应用于疾病诊断或治疗方法的相关应用中。